126 related articles for article (PubMed ID: 35110376)
1. Renin-Angiotensin-Aldosterone System Inhibitors and the Risk of AKI in COVID-19 Compared with Influenza.
Birkelo BC; Parr SK; Perkins AM; Greevy RA; Arroyo JP; Hung AM; Vincz AJ; Shah SC; Kapoor T; Matheny ME; Siew ED
Clin J Am Soc Nephrol; 2022 Mar; 17(3):423-425. PubMed ID: 35110376
[No Abstract] [Full Text] [Related]
2. Combined use of nonsteroidal anti-inflammatory drugs with diuretics and/or renin-angiotensin system inhibitors in the community increases the risk of acute kidney injury.
Dreischulte T; Morales DR; Bell S; Guthrie B
Kidney Int; 2015 Aug; 88(2):396-403. PubMed ID: 25874600
[TBL] [Abstract][Full Text] [Related]
3. Estimating the risk of acute kidney injury associated with use of diuretics and renin angiotensin aldosterone system inhibitors: A population based cohort study using the clinical practice research datalink.
Scott J; Jones T; Redaniel MT; May MT; Ben-Shlomo Y; Caskey F
BMC Nephrol; 2019 Dec; 20(1):481. PubMed ID: 31888533
[TBL] [Abstract][Full Text] [Related]
4. The right time and "Pl ACE": optimal management of perioperative angiotensin-converting enzyme inhibitors.
Chopra V; Wijeysundera DN
J Hosp Med; 2014 May; 9(5):334-6. PubMed ID: 24799361
[No Abstract] [Full Text] [Related]
5. Renin-Angiotensin System Blockade after Acute Kidney Injury (AKI) and Risk of Recurrent AKI.
Hsu CY; Liu KD; Yang J; Glidden DV; Tan TC; Pravoverov L; Zheng S; Go AS
Clin J Am Soc Nephrol; 2020 Jan; 15(1):26-34. PubMed ID: 31843974
[TBL] [Abstract][Full Text] [Related]
6. The effect of renin-angiotensin-aldosterone system blockade on contrast-induced acute kidney injury: a propensity-matched study.
Rim MY; Ro H; Kang WC; Kim AJ; Park H; Chang JH; Lee HH; Chung W; Jung JY
Am J Kidney Dis; 2012 Oct; 60(4):576-82. PubMed ID: 22658321
[TBL] [Abstract][Full Text] [Related]
7. Prescription of renin-angiotensin system blockers and risk of acute kidney injury: a population-based cohort study.
Mansfield KE; Nitsch D; Smeeth L; Bhaskaran K; Tomlinson LA
BMJ Open; 2016 Dec; 6(12):e012690. PubMed ID: 28003286
[TBL] [Abstract][Full Text] [Related]
8. Renin-angiotensin system blocker use and the risk of acute kidney injury after colorectal cancer surgery: a population-based cohort study.
Slagelse C; Gammelager H; Iversen LH; Liu KD; Sørensen HTT; Christiansen CF
BMJ Open; 2019 Nov; 9(11):e032964. PubMed ID: 31753901
[TBL] [Abstract][Full Text] [Related]
9. Preoperative angiotensin axis blockade therapy, intraoperative hypotension, and the risks of postoperative acute kidney injury.
Onuigbo MA
J Hosp Med; 2014 Sep; 9(9):610. PubMed ID: 24932783
[No Abstract] [Full Text] [Related]
10. COVID-19, hypertension, and renin-angiotensin-aldosterone system inhibitors: Much ado about nothing or real problem to be solved?
Tadic M; Cuspidi C
J Clin Hypertens (Greenwich); 2020 Nov; 22(11):1984-1986. PubMed ID: 32951351
[No Abstract] [Full Text] [Related]
11. In response to "Preoperative angiotensin axis blockade therapy, intraoperative hypotension, and the risks of postoperative acute kidney injury".
Hennrikus E; Mets B
J Hosp Med; 2014 Sep; 9(9):611. PubMed ID: 24932910
[No Abstract] [Full Text] [Related]
12. Exposure to inhibitors of the renin-angiotensin system is a major independent risk factor for acute renal failure induced by sucrose containing intravenous immunoglobulins. A case-control study.
Onuigbo MA
Pharmacoepidemiol Drug Saf; 2012 Mar; 21(3):320-2. PubMed ID: 22238243
[No Abstract] [Full Text] [Related]
13. COVID-19 and inhibitors of the renin-angiotensin-aldosterone system.
Hussain M; Jabeen Q; Ahmad FU; Kashif-Ur-Rehman ; Fatima M; Shaukat S; Majeed A; Barkat MQ; Wu X
Expert Rev Anti Infect Ther; 2021 Jul; 19(7):815-816. PubMed ID: 33198546
[No Abstract] [Full Text] [Related]
14. Reply to the commentary by Onuigbo on the article "Exposure to inhibitors of the renin-angiotensin system is a major independent risk factor for acute renal failure induced by sucrose-containing intravenous immunoglobulins. A case-control study".
Moulis G; Sailler L; Montastruc JL
Pharmacoepidemiol Drug Saf; 2012 Aug; 21(8):900-1. PubMed ID: 22696169
[No Abstract] [Full Text] [Related]
15. Angiotensin-Converting-Enzyme 2 and Renin-Angiotensin System Inhibitors in COVID-19: An Update.
Shukla AK; Banerjee M
High Blood Press Cardiovasc Prev; 2021 Mar; 28(2):129-139. PubMed ID: 33635533
[TBL] [Abstract][Full Text] [Related]
16. Use of Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers and Acute Kidney Disease after an Episode of AKI: A Multicenter Prospective Cohort Study.
Hines A; Li X; Ortiz-Soriano V; Saleh S; Litteral J; Ruiz-Conejo M; Wald R; Silver SA; Neyra JA
Am J Nephrol; 2020; 51(4):266-275. PubMed ID: 32088714
[TBL] [Abstract][Full Text] [Related]
17. Rate and Outcome of Acute Kidney Injury Following Hip Fracture Surgery in Diabetic Older Patients Treated with Renin-Angiotensin-Aldosterone Antagonists.
Frenkel Rutenberg T; Bdeir A; Rozen-Zvi B; Rosenthal Y; Velkes S; Weiss A; Beloosesky Y
Drugs Aging; 2019 Jul; 36(7):667-674. PubMed ID: 30949984
[TBL] [Abstract][Full Text] [Related]
18. COVID-19, hypertension, and RAAS blockers: the BRACE-CORONA trial.
Mancia G
Cardiovasc Res; 2020 Dec; 116(14):e198-e199. PubMed ID: 33245754
[No Abstract] [Full Text] [Related]
19. Adverse impact of renin-angiotensin system blockade on the clinical course in hospitalized patients with severe COVID-19: a retrospective cohort study.
Lim JH; Cho JH; Jeon Y; Kim JH; Lee GY; Jeon S; Noh HW; Lee YH; Lee J; Chang HH; Jung HY; Choi JY; Park SH; Kim CD; Kim YL; Kim SW
Sci Rep; 2020 Nov; 10(1):20250. PubMed ID: 33219294
[TBL] [Abstract][Full Text] [Related]
20. Safety and Efficacy of Renin-Angiotensin-Aldosterone System Inhibitors in COVID-19 Population.
Sattar Y; Mukuntharaj P; Zghouzi M; Suleiman AM; Attique H; Ullah W; Sana MK; Zaher N; Mehmood M; Doshi RP; Panchal A; Mir T; Nadeem M; Ali OE; Mohamed M; Bagur R; Elgendy IY; Mamas MA; Alraies MC
High Blood Press Cardiovasc Prev; 2021 Jul; 28(4):405-416. PubMed ID: 34181203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
